Literature DB >> 29119456

Heterogeneity of longitudinal and circumferential contraction in relation to late gadolinium enhancement in hypertrophic cardiomyopathy patients with preserved left ventricular ejection fraction.

Keita Sakamoto1,2, Noriko Oyama-Manabe3, Osamu Manabe4, Tadao Aikawa5, Yasuka Kikuchi1,6, Harue Sasai-Masuko5, Masanao Naya5, Kohsuke Kudo1, Fumi Kato1, Nagara Tamaki7, Hiroki Shirato2.   

Abstract

PURPOSE: To evaluate heterogeneity of myocardial contraction in relation to extensive late gadolinium enhancement (LGE) in hypertrophic cardiomyopathy (HCM) patients with preserved left ventricular ejection fraction, using fast strain-encoded magnetic resonance imaging.
MATERIALS AND METHODS: Twenty-two HCM patients and 24 age-matched control subjects were included in this retrospective study. The regional and global peak values of longitudinal and circumferential strain (LSregional, LSglobal, CSregional, CSglobal), and their regional heterogeneities were evaluated using coefficients of variation (LSCoV, CSCoV) in relation to LGE. Receiver operating characteristic curve analysis was performed to identify patients with a total left ventricular myocardial LGE ≥ 15%.
RESULTS: LSglobal in HCM patients was significantly decreased compared to that in controls (- 14.4 ± 2.4% vs - 17.2 ± 2.0%; p = 0.0004), while CSglobal was not (p = 1.0). Negative LGE segments demonstrated decreased LSregional in HCM patients compared to in controls (p < 0.0001), while CSregional was not decreased. CSCoV demonstrated the largest area under the curve (AUC) (0.91), with high sensitivity (83%) and specificity (94%) for detection of HCM patients with extensive LGE, while the AUC of LSCoV was low (0.49).
CONCLUSION: The heterogeneity in CSregional has a high diagnostic value for detection of HCM patients with extensive LGE.

Entities:  

Keywords:  Circumferential strain; Hypertrophic cardiomyopathy; Late gadolinium enhancement; Longitudinal strain; Strain-encoded magnetic resonance imaging

Mesh:

Substances:

Year:  2017        PMID: 29119456     DOI: 10.1007/s11604-017-0700-5

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  27 in total

1.  Prognostic value of intra-left ventricular electromechanical asynchrony in patients with hypertrophic cardiomyopathy.

Authors:  Antonello D'Andrea; Pio Caso; Sergio Severino; Sergio Cuomo; Giovanbattista Capozzi; Paolo Calabrò; Gennaro Cice; Luigi Ascione; Marino Scherillo; Raffaele Calabrò
Journal:  Eur Heart J       Date:  2005-12-19       Impact factor: 29.983

2.  Three-dimensional speckle tracking echocardiography for the preclinical diagnosis of hypertrophic cardiomyopathy.

Authors:  Mohamed F A Aly; Wessel P Brouwer; Sebastiaan A Kleijn; Albert C van Rossum; Otto Kamp
Journal:  Int J Cardiovasc Imaging       Date:  2014-01-30       Impact factor: 2.357

3.  Real-time single-heartbeat fast strain-encoded imaging of right ventricular regional function: normal versus chronic pulmonary hypertension.

Authors:  Monda L Shehata; Tamer A Basha; Wahid H Tantawy; Joao A Lima; Jens Vogel-Claussen; David A Bluemke; Paul M Hassoun; Nael F Osman
Journal:  Magn Reson Med       Date:  2010-07       Impact factor: 4.668

4.  Identification and further differentiation of subendocardial and transmural myocardial infarction by fast strain-encoded (SENC) magnetic resonance imaging at 3.0 Tesla.

Authors:  Noriko Oyama-Manabe; Naoki Ishimori; Hiroyuki Sugimori; Marc Van Cauteren; Kohsuke Kudo; Osamu Manabe; Tomoyuki Okuaki; Tamotsu Kamishima; Yoichi M Ito; Hiroyuki Tsutsui; Khin Khin Tha; Satoshi Terae; Hiroki Shirato
Journal:  Eur Radiol       Date:  2011-06-18       Impact factor: 5.315

5.  Clinical and imaging description of the Maron subtypes of hypertrophic cardiomyopathy.

Authors:  Patricia Reant; Erwan Donal; Frederic Schnell; Amelie Reynaud; Magalie Daudin; Xavier Pillois; Marina Dijos; Mathieu Landelle; Jerome Peyrou; Claire Cornolle; François Laurent; Michel Montaudon; Raymond Roudaut; Stephane Lafitte
Journal:  Int J Cardiovasc Imaging       Date:  2014-11-25       Impact factor: 2.357

6.  Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.

Authors:  Raymond H Chan; Barry J Maron; Iacopo Olivotto; Michael J Pencina; Gabriele Egidy Assenza; Tammy Haas; John R Lesser; Christiane Gruner; Andrew M Crean; Harry Rakowski; James E Udelson; Ethan Rowin; Massimo Lombardi; Franco Cecchi; Benedetta Tomberli; Paolo Spirito; Francesco Formisano; Elena Biagini; Claudio Rapezzi; Carlo Nicola De Cecco; Camillo Autore; E Francis Cook; Susie N Hong; C Michael Gibson; Warren J Manning; Evan Appelbaum; Martin S Maron
Journal:  Circulation       Date:  2014-08-05       Impact factor: 29.690

7.  Clinical characteristics and outcomes of dilated phase of hypertrophic cardiomyopathy: report from the registry data in Japan.

Authors:  Daisuke Goto; Shintaro Kinugawa; Sanae Hamaguchi; Mamoru Sakakibara; Miyuki Tsuchihashi-Makaya; Takashi Yokota; Satoshi Yamada; Hisashi Yokoshiki; Hiroyuki Tsutsui
Journal:  J Cardiol       Date:  2012-10-15       Impact factor: 3.159

8.  Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging.

Authors:  Zoran B Popović; Deborah H Kwon; Micky Mishra; Adisai Buakhamsri; Neil L Greenberg; Maran Thamilarasan; Scott D Flamm; James D Thomas; Harry M Lever; Milind Y Desai
Journal:  J Am Soc Echocardiogr       Date:  2008-12       Impact factor: 5.251

9.  Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.

Authors:  Barry J Maron; Paolo Spirito; Win-Kuang Shen; Tammy S Haas; Francesco Formisano; Mark S Link; Andrew E Epstein; Adrian K Almquist; James P Daubert; Thorsten Lawrenz; Giuseppe Boriani; N A Mark Estes; Stefano Favale; Marco Piccininno; Stephen L Winters; Massimo Santini; Sandro Betocchi; Fernando Arribas; Mark V Sherrid; Gianfranco Buja; Christopher Semsarian; Paolo Bruzzi
Journal:  JAMA       Date:  2007-07-25       Impact factor: 56.272

10.  ESUR guideline: gadolinium-based contrast media and nephrogenic systemic fibrosis.

Authors:  Henrik S Thomsen
Journal:  Eur Radiol       Date:  2007-10       Impact factor: 7.034

View more
  3 in total

1.  Strain-encoded magnetic resonance: a method for the assessment of myocardial deformation.

Authors:  Grigorios Korosoglou; Sorin Giusca; Nina P Hofmann; Amit R Patel; Tomas Lapinskas; Burkert Pieske; Henning Steen; Hugo A Katus; Sebastian Kelle
Journal:  ESC Heart Fail       Date:  2019-04-25

2.  Echocardiography and cardiovascular magnetic resonance based evaluation of myocardial strain and relationship with late gadolinium enhancement.

Authors:  Jennifer Erley; Davide Genovese; Natalie Tapaskar; Nazia Alvi; Nina Rashedi; Stephanie A Besser; Keigo Kawaji; Neha Goyal; Sebastian Kelle; Roberto M Lang; Victor Mor-Avi; Amit R Patel
Journal:  J Cardiovasc Magn Reson       Date:  2019-08-08       Impact factor: 5.364

3.  A multi-vendor, multi-center study on reproducibility and comparability of fast strain-encoded cardiovascular magnetic resonance imaging.

Authors:  Jennifer Erley; Victoria Zieschang; Tomas Lapinskas; Aylin Demir; Stephanie Wiesemann; Markus Haass; Nael F Osman; Orlando P Simonetti; Yingmin Liu; Amit R Patel; Victor Mor-Avi; Orhan Unal; Kevin M Johnson; Burkert Pieske; Jochen Hansmann; Jeanette Schulz-Menger; Sebastian Kelle
Journal:  Int J Cardiovasc Imaging       Date:  2020-02-13       Impact factor: 2.357

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.